Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway

• Autor(es): Saad, Sara Teresinha Olalla
• Data: 2017
• Origem: Oasisbr
• Assunto(s): CÉLULAS-TRONCO
• Tipo de Documento: Artigo científico
• Idioma: Inglês